HURA
Sign in
TuHURA Biosciences Inc
Save
216.92M
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Biotechnology
Industry
TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy.
Similar securities
Based on sector and market capitalization
Report issue